Relmada Therapeutics: As of Dec 31, 2023, Had Cash, Cash Equivalents, Short-Term Investments of Approximately $96.3M, Compared to Cash, Cash Equivalents, Short-Term Investments of Approximately $148.3M at Dec 31, 2022 >RLMD
Relmada Therapeutics: As of Dec 31, 2023, Had Cash, Cash Equivalents, Short-Term Investments of Approximately $96.3M, Compared to Cash, Cash Equivalents, Short-Term Investments of Approximately $148.3M at Dec 31, 2022 >RLMD
Relmada Therapeutics：截至2023年12月31日，现金、现金等价物、短期投资约为9,630万美元，而截至2022年12月31日，现金、现金等价物、短期投资约为1.483亿美元 >RLMD
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册